Cargando…

Transcriptional Regulation of Siglec-15 by ETS-1 and ETS-2 in Hepatocellular Carcinoma Cells

Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) has been identified as a crucial immune suppressor in human cancers, comparable to programmed cell death 1 ligand (PD-L1). However, the regulatory mechanisms underlying its transcriptional upregulation in human cancers remain largely unkn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Kaiqin, Wu, Yuecheng, Lin, Hanbin, Fang, Menghan, Xue, Chaorong, Lin, Xu, Lin, Xinjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821606/ https://www.ncbi.nlm.nih.gov/pubmed/36614238 http://dx.doi.org/10.3390/ijms24010792

Ejemplares similares

Long Noncoding RNA TUG1 Inhibits Tumor Progression through Regulating Siglec-15-Related Anti-Immune Activity in Hepatocellular Carcinoma
por: Ren, Yanyi, et al.
Publicado: (2022)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression
por: Zheng, Yayun, et al.
Publicado: (2020)

Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022)

Normalization cancer immunotherapy: blocking Siglec-15!
por: Cao, Guangchao, et al.
Publicado: (2019)

Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases
por: Angata, Takashi
Publicado: (2020)

MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells
por: Wang, Hongbo, et al.
Publicado: (2022)

Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
por: Wang, Jun, et al.
Publicado: (2019)

Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma
por: Zhao, Ju, et al.
Publicado: (2022)

Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis
por: Li, Baihui, et al.
Publicado: (2020)

LINC00973 is involved in cancer immune suppression through positive regulation of Siglec‐15 in clear‐cell renal cell carcinoma
por: Liu, Yanbin, et al.
Publicado: (2020)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Siglec15 facilitates the progression of non-small cell lung cancer and is correlated with spinal metastasis
por: Liang, Haifeng, et al.
Publicado: (2022)

Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis
por: Dewi, Intan M.W., et al.
Publicado: (2021)

High affinity monoclonal antibody targeting Siglec-15 for cancer immunotherapy
por: He, Fei, et al.
Publicado: (2021)

Hepatitis B doubly spliced protein (HBDSP) promotes hepatocellular carcinoma cell apoptosis via ETS1/GATA2/YY1-mediated p53 transcription
por: Xu, Xiazhen, et al.
Publicado: (2023)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma
por: Vishnoi, Kanchan, et al.
Publicado: (2022)

Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy
por: Liu, Xiaodi, et al.
Publicado: (2023)

Integrative Analysis of Siglec-15 mRNA in Human Cancers Based on Data Mining
por: Li, Qiu-ting, et al.
Publicado: (2020)

Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway
por: Fan, Meng-ke, et al.
Publicado: (2021)

Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas
por: Wang, Jinchao, et al.
Publicado: (2023)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells
por: Liao, Yu-Lun, et al.
Publicado: (2012)

Blocking siglec-10(hi) tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
por: Xiao, Nan, et al.
Publicado: (2021)

Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters
por: Quirino, Michael Williams Leal, et al.
Publicado: (2021)

Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma
por: Chen, Xianlong, et al.
Publicado: (2022)

ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas
por: Yang, Hanseul, et al.
Publicado: (2015)

KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma
por: Sun, Yue-Feng, et al.
Publicado: (2020)

Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells
por: Xie, Jiexiong, et al.
Publicado: (2018)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Core needle biopsies alter the amounts of CCR5, Siglec-15, and PD-L1 positivities in breast carcinoma
por: Mutka, Minna, et al.
Publicado: (2023)

Unveiling the molecular features, relevant immune and clinical characteristics of SIGLEC15 in thyroid cancer
por: Hou, Xiaofeng, et al.
Publicado: (2022)

Prognostic value of Siglec-15 expression in patients with solid tumors: A meta-analysis
por: Jiang, Kui-Ying, et al.
Publicado: (2023)

Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma
por: Zhan, Weixiang, et al.
Publicado: (2023)

Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia
por: Pillsbury, Claire E., et al.
Publicado: (2023)

A pan‐cancer blueprint of genomics alterations and transcriptional regulation of Siglecs, and implications in prognosis and immunotherapy responsiveness
por: Mei, Song, et al.
Publicado: (2023)

Roles and regulations of the ETS transcription factor ELF4/MEF
por: Suico, Mary Ann, et al.
Publicado: (2017)

Chromatin remodelling factor BAF155 protects hepatitis B virus X protein (HBx) from ubiquitin-independent proteasomal degradation
por: Chen, Huijing, et al.
Publicado: (2019)

Epithelium-Specific ETS (ESE)-1 upregulated GP73 expression in hepatocellular carcinoma cells
por: Wang, Fang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rh42m9eeiqa36anvegge921pf9